期刊文献+

颅内动脉狭窄患者血管成形术与支架置入术临床和血管造影结果比较:病例系列研究 被引量:4

Comparison of clinical and angiographic outcomes of angioplasty and stenting in patients with intracranial arterial stenosis: a case series study
原文传递
导出
摘要 目的比较球囊扩张血管成形术、球囊扩张支架置人术和自膨式支架置人术治疗颅内动脉狭窄性病变的临床效果和影像学结果。方法选择南京卒中注册系统中因颅内动脉狭窄而行球囊扩张血管成形术或支架置入术的患者,根据手术方式的不同分为球囊扩张支架置入组、自膨式支架置入组和球囊扩张血管成形术组,比较其手术成功率、围手术期并发症发生率以及显著残余狭窄发生率。收集术后1、3、6、12和24个月时定期门诊或住院随访的临床和血管造影资料,比较2年内缺血性卒中和(或)死亡发生率以及再狭窄发生率。采用多因素Cox风险比例分析缺血性卒中复发和(或)死亡以及再狭窄的危险因素。结果183例患者共192处狭窄性病变行球囊扩张血管成形术或支架置入术治疗,其中球囊扩张支架置入组92例,自膨式支架置入组42例,球囊扩张血管成形组49例,术前狭窄程度分别为(80.25-12.8)%、(76.3±11.9)%和(89.7±10.2)%(F=15.863,P=0.000),其他基线资料均无显著性差异。球囊扩张支架置入组、自膨式支架置人组和球囊扩张血管成形术成功率分别为96.7%、95.2%和91.8%(r=1.646,P=0.439),围手术期并发症发生率分别为6.5%、14.3%和10.2%(Fisher精确概率法P=0.334),缺血性卒中和(或)死亡发生率分别为9.2%、4.8%和13.0%(Fisher精确概率法P=0.458),均无显著性差异。影像学随访显示,球囊扩张血管成形组再狭窄发生率为48.5%,虽然高于球囊扩张支架置入组的27.7%和自膨式支架置入组的34.8%,但无显著性差异(x2=4.176,P:0.124)。多因素Cox比例风险分析显示,球囊扩张皿管成形是术后再狭窄的独立危险因素(风险比2.490,95%可信区间1.247~4.969,P=0.010)。结论与球囊扩张式支架置入相比,球囊扩张血管成形更易发生再狭窄,但其与术后缺血性卒中复发和(或)死亡风险无关。 Objective To compare the clinical efficacy and angiographic outcomes of balloon dilation angioplasty, balloon-expandable stent implantation and self-expanding stent implantation in the treatment of intracranial arterial stenosis. Methods The patients with intracranial arterial stenosis who met the indications of shrgical intervention treated with balloon dilatation angioplasty and stent placement were selected from Nanjing Stroke Registry Program. According to the different interventional procedures, the patients were divided into the balloon expandable stenting group, the self-expanding stents group and the balloon dilatation angioplasty group. The success rate of surgery, the perioperative complication rate and the significant residual stenosis rate were cmpared among the three groups. The clinical and angiographic assessments were performed through 1-, 3-, 6-, 12- and 24-month regular outpatient or inpatient follow-up after procedure. The incidences of ischemic strokeand/or death and restenosis within 2 years were compared. Multivariate Cox proportional hazards analysis was used to analyze the risk factors for recurrent ischemic stroke and/or death and restenosis. Results A total of 183 patients with 192 stenoses performed balloon dilatation angioplasty or stenting, in which 92 were in the balloon expandable stenting group, 42 were in the serf-expanding stents goup and 49 in the balloon dilatation angioplasty group, Their preoperative stenosis rates were 80. 2 ±12. 8% ,76. 3 ± 11. 9% and 89. 7± 10. 2%, respectively (F = 15. 863, P =0. 000). There were no significant differences in other baseline data. The success rates of surgery in the balloon expandable stenting group, self-expanding stents group and balloon dilatation angioplasty group were 96. 7%, 95. 2% and 91.8%, respectively (x2 = 1. 646, P =0. 439). The perioperative complication rates were 6. 5%, 14. 3% and 10. 2%, respectively (Fisher exact test, P =0. 334). The imaging follow-up showed that the restenosis rate in the balloon dilatation angioplasty group was 48. 5%. Although it was high than 27. 7% in the balloon expandable stenting group and 34. 8% in the self-expanding stents group, there were no significant differences (X2 = 4. 176, P = 0. 124). Multivariate Cox proportional hazards analysis showed that balloon dilatation angioplasty was an independent risk factor for restenosis after procedure (hazard ratio 2. 490, 95% confidence interval 1. 247 - 4. 969, P = 0. 010). Conclusions Compared to the balloon expandable stenting, the balloon dilatation angioplasty is more likely to have restenosis, but it is not associated with the risks of postoperative recurrent iscliemic stroke and/or death.
出处 《国际脑血管病杂志》 北大核心 2012年第3期182-188,共7页 International Journal of Cerebrovascular Diseases
基金 基金项目:国家自然基金(81070923,81100870)
关键词 颅内动脉硬化 血管成形术 支架 脑血管造影术 治疗结果 Intracranial Arteriosclerosis Angioplasty Stents Cerebral Angiography Treatment Outcome
  • 相关文献

参考文献19

  • 1Wong KS, Huang YN, Gao S, et al. Intracxanial stenosis in Chinese patients with acute stroke. Neurology, 1998, 50: 812-813.
  • 2Chimowitz MI, Lynn MJ, Howlett-Sixfith H, et al; Warf'in-AspirinSymptomatic Intracranial Disease Trial Investigators. Compaison of w'f'in and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med, 2005, 352: 1305-1316.
  • 3Qureshi A1, Suri MF, Siddiqui AM, et al, Clinical and angiographic results of dilatation procedures for symptomatic intracranial athero- sclerotic disease. J Neuroimaging, 2005, 15: 240-249.
  • 4mdt TM Jr, ith HC, Canpbell JK, et al. Transl angioplasty for bosilar artery stenosis. Mayo Clin Proc, 1980, 55: 673-680.
  • 5Taylor RA, Kasner SE. Treatment of intracranial arterial stenosis. Epert Rev Neurother, 2006, 6: 1685-1694.
  • 6Siddiq F, Vazquez G, Memon MZ, et al. Comparison of primary mgioplasty with stoat placeraent for treating syraptorratic intracranial atherosclerotic diseases: a rmlticenter study. Stroke, 2008, 39: 2505- 2510.
  • 7Siddiq F, Meanon MZ, Vazquez G, et al. Comparison between primary angioplasty and stent placement for syrnptormtic intracranial atheco- sderotic disease: meta-analysis of case series. Neurosur'y, 2(D9, 65: 1024-1034.
  • 8Goschel K, Schnaudigel S, Pilffam SM, et al. A systematic review on outcome after stenting for intracmnial atherosclerosis. Stroke, 2009, 40: e340-e.347.
  • 9Samuels OB, Joseph GJ, Lynn M J, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol, 2000, 21 : 643-646.
  • 10Mazighi M, Abou-Chebl A. Stenting and prevention of ischemic stroke. Curt Drug Targets, 2007, 8: 867-873.

同被引文献42

  • 1中华医学会神经病学分会脑血管病学组缺血性脑血管病血管内介入诊疗指南撰写组.中国缺血性脑血管病血管内介入诊疗指南[J].中华神经科杂志,2011,.
  • 2de Donato G, Setacci C, Deloose K, et al. Long-term results of carotid artery stenting, J Vasc Surg, 2008, 48: 1431-1441.
  • 3Gupta R, Zaidat O, Majid A. US multicenter experience with the Wingspan stent system for the treatment of intracnmial atheromatous disease: periprocedural results. Stroke, 2007, 38: e80.
  • 4Grischel K, Schnaudigel S, Pilgcam SM, et al. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke, 2009, 40: e340-e347.
  • 5Zhu SG, Zhang RL, Liu WH, et al. Predictive hctors for in-stent restenosis after baUoon-mounted stent placement for symptomatic intracranial atherosclerosis. Eur J Vasc Endovasc Surg, 2010, 40: 499-506.
  • 6Koppensteiner R, Spring S, Amann-Vesti BR, et al. Low-molecular- weight heparin for prevention of restenosis after femoropopliteal percutanenus transluminal angioplasty: a randomized controlled trial. J Vasc Surg, 2006, 44: 1247-1253.
  • 7Willfort-Ehringer A, Ahmadi R, Gschwandtner M E, et al. Healing of carotid stents: a prospective duplex ultrasound study. J Endovasc Ther, 2003, 10: 636-642.
  • 8Wakeyama T, Ogawa H, Iida H, et al. Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin 11 receptor antagonist (ISHIN) trial. Circ J, 2003, 67: 519-524.
  • 9Schulz S, Sibbing D, Braun S, et al. Platelet response to clopidog'el and restenosis in patients treated predominantly with drug-eluting stents. Am Heart J, 2010, 160: 355-361.
  • 10Jeske WP, Fareed J, Hoppensteadt DA, et al. PharmacoloK of argatroban. Eert Rev Hematol, 2010, 3: 527-539.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部